Cabaletta Bio (CABA) Other Accumulated Expenses (2018 - 2025)
Cabaletta Bio (CABA) recorded quarterly Other Accumulated Expenses of $80000.0 in Q4 2025, up 166.67% quarter-over-quarter from $30000.0 in Q3 2025, and up 100.0% on a YoY basis from $40000.0 in Q4 2024.
Cabaletta Bio (CABA) Other Accumulated Expenses (2018 - 2025) Analysis & Trends
Cabaletta Bio's Other Accumulated Expenses history runs 8 years deep, the most recent figure standing at $80000.0 for Q4 2025.
- In Q4 2025, Other Accumulated Expenses rose 100.0% year-over-year to $80000.0; the TTM figure through Dec 2025 stood at $80000.0 (up 100.0% YoY), while the FY2025 annual figure was $80000.0, up 100.0% from the prior year.
- Other Accumulated Expenses was $80000.0 for Q4 2025 at Cabaletta Bio, up from $30000.0 in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $83000.0 in Q1 2021 to a low of $16000.0 in Q2 2025.
- Historically, Other Accumulated Expenses has averaged $44150.0 across 5 years, with a median of $43500.0 in 2021.
- The sharpest annual moves came in 2021 and 2025: Other Accumulated Expenses slumped 62.86% in 2021, then surged 100.0% in 2025.
- A 5-year view of Other Accumulated Expenses shows it stood at $54000.0 in 2021, then slipped by 27.78% to $39000.0 in 2022, then grew by 2.56% to $40000.0 in 2023, then changed by 0.0% to $40000.0 in 2024, then soared by 100.0% to $80000.0 in 2025.
- The last three Other Accumulated Expenses figures came in at $80000.0 (Q4 2025), $30000.0 (Q3 2025), and $16000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Cabaletta Bio | 151.84 Mn | 18.24 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 80,000.00 |
| Sep 30, 2025 | 30,000.00 |
| Jun 30, 2025 | 16,000.00 |
| Mar 31, 2025 | 50,000.00 |
| Dec 31, 2024 | 40,000.00 |
| Sep 30, 2024 | 30,000.00 |
| Jun 30, 2024 | 20,000.00 |
| Mar 31, 2024 | 50,000.00 |
| Dec 31, 2023 | 40,000.00 |
| Sep 30, 2023 | 30,000.00 |
| Jun 30, 2023 | 20,000.00 |
| Mar 31, 2023 | 50,000.00 |
| Dec 31, 2022 | 39,000.00 |
| Sep 30, 2022 | 71,000.00 |
| Jun 30, 2022 | 23,000.00 |
| Mar 31, 2022 | 58,000.00 |
| Dec 31, 2021 | 54,000.00 |
| Sep 30, 2021 | 52,000.00 |
| Jun 30, 2021 | 47,000.00 |
| Mar 31, 2021 | 83,000.00 |